Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 7, 2016 – The FDA approved Duchesnay’s Bonjesta (doxylamine/pyridoxine) for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.
Return to publications